Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use

Last updated: January 23, 2024
Sponsor: University of California, San Francisco
Overall Status: Completed

Phase

N/A

Condition

Atopic Dermatitis

Allergy

Eczema (Atopic Dermatitis)

Treatment

SkinTracker Mobile App

Clinical Study ID

NCT04404075
19-28676
  • Ages > 13
  • All Genders

Study Summary

Design and beta-test a research-oriented mobile health app to assess disease activity, quality of life, treatment patterns, adverse medication effects, and lifestyle factors in patients with atopic dermatitis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Ability to provide written informed consent and comply with the protocol.
  2. At least 13 years of age.
  3. Diagnosis of atopic dermatitis by dermatologist for at least 6 months.
  4. Physical exam within clinically acceptable limits.
  5. Own or have access to a mobile device that is compatible with study mobile applicationSkinTracker.

Exclusion

Exclusion Criteria:

  1. Subject is unable to provide written informed consent or comply with the protocol.
  2. Unable to input data into SkinTracker mobile app.
  3. Subject is younger than 13 years of age.
  4. Serious known infection.
  5. History of immunosuppression (including human immunodeficiency virus (HIV)).
  6. History of malignancy within 5 years prior to screening visit, except completelytreated in situ carcinoma of the cervix, completely treated and resolvednon-metastatic squamous or basal cell carcinoma of the skin.
  7. Severe concomitant illness.
  8. Physical exam not within clinically acceptable limits.
  9. Subjects possess other diagnoses that, in the investigator's opinion, preclude him/herfrom safely participating in this study or interfere

Study Design

Total Participants: 11
Treatment Group(s): 1
Primary Treatment: SkinTracker Mobile App
Phase:
Study Start date:
April 25, 2022
Estimated Completion Date:
May 12, 2023

Study Description

Mobile health technology, including smartphone apps and wearable monitors, has tremendous potential to transform clinical research. Recording of patient outcomes on a smartphone device and camera in the home setting can greatly reduce the number of in person research visits, saving tremendous costs, time, and effort associated with data entry. This also allows for easier recruitment of study subjects, who can be enrolled in geographic locations beyond academic research centers. After FDA approval of a therapy, mobile health technology can help researchers understand how that particular therapy is being used in a real-world setting, including frequency of use, adverse events, and impact of use on disease symptoms and patient quality of life. In this study, the investigators will create a mobile app to help the atopic dermatitis community understand the types of data and quality of data that can be gathered from atopic dermatitis patients longitudinally. A review of existing atopic dermatitis mobile apps on the market reveals they are consumer-oriented and may not be able to fully capture high-quality research data. The investigator proposed app is specifically geared for research, and thus fills an important gap. The research team will develop SkinTracker, a research-oriented eczema app to longitudinally track atopic dermatitis severity, symptoms, quality of life, physical activity, medication usage, and adverse events in a real-world setting.

Connect with a study center

  • UCSF Psoriasis and Skin Treatment Center

    San Francisco, California 94118
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.